Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge

被引:95
作者
Church, LWP
Le, TP
Bryan, JP
Gordon, DM
Edelman, R
Fries, L
Davis, JR
Herrington, DA
Clyde, DF
Shmuklarsky, MJ
Schneider, I
McGovern, TW
Chulay, JD
Ballou, WR
Hoffman, SL
机构
[1] NATL NAVAL MED CTR, MALARIA PROGRAM, ROCKVILLE, MD 20852 USA
[2] UNIFORMED SERV UNIV HLTH SCI, DEPT PREVENT MED & BIOMETR, BETHESDA, MD 20814 USA
[3] USA, MED RES INST INFECT DIS, FT DETRICK, MD 21702 USA
[4] UNIV MARYLAND, CTR VACCINE DEV, BALTIMORE, MD 21201 USA
[5] JOHNS HOPKINS UNIV, CTR IMMUNIZAT RES, BALTIMORE, MD USA
[6] WALTER REED ARMY MED CTR, WALTER REED ARMY INST RES, DIV COMMUNICABLE DIS, WASHINGTON, DC 20307 USA
[7] WALTER REED ARMY MED CTR, WALTER REED ARMY INST RES, DIV EXPT THERAPEUT, WASHINGTON, DC 20307 USA
关键词
D O I
10.1086/513990
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To determine the characteristics of clinical illness accompanying Plasmodium falciparum infection induced by controlled exposure to infected mosquitoes, records of 118 volunteers participating in studies conducted between 1985 and 1992 were reviewed. One hundred fourteen volunteers (97%) reported at least one symptom attributable to malaria, with fatigue, myalgias or arthralgias, headache, and chills most commonly reported. The median duration of symptoms was 3 days. Fever was recorded in 61% of volunteers; 4 volunteers had temperatures >40 degrees C. Neutropenia and thrombocytopenia were present in 9% and 12% of volunteers, respectively. Despite counts as low as 658/mu L (neutrophils) or 73,000/mu L (platelets), no secondary infectious or hemorrhagic complications occurred. In all cases, volunteers recovered completely and laboratory values returned to baseline after specific antimalarial therapy. Recrudescence did not occur in any volunteer. In this model, mosquito inoculation of P. falciparum is a reliable, safe, and well-tolerated method of experimental challenge.
引用
收藏
页码:915 / 920
页数:6
相关论文
共 36 条
[1]  
BALLOU WR, 1987, LANCET, V1, P1277
[2]   DISCORDANCE BETWEEN METAANALYSES AND LARGE-SCALE RANDOMIZED, CONTROLLED TRIALS - EXAMPLES FROM THE MANAGEMENT OF ACUTE MYOCARDIAL-INFARCTION [J].
BORZAK, S ;
RIDKER, PM .
ANNALS OF INTERNAL MEDICINE, 1995, 123 (11) :873-877
[3]  
BOUREE P, 1994, PRESSE MED, V23, P449
[4]   INFECTIVITY TO MOSQUITOS OF PLASMODIUM-FALCIPARUM CLONES GROWN-INVITRO FROM THE SAME ISOLATE [J].
BURKOT, TR ;
WILLIAMS, JL ;
SCHNEIDER, I .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1984, 78 (03) :339-341
[5]   MALARIA TRANSMITTED TO HUMANS BY MOSQUITOS INFECTED FROM CULTURED PLASMODIUM-FALCIPARUM [J].
CHULAY, JD ;
SCHNEIDER, I ;
COSGRIFF, TM ;
HOFFMAN, SL ;
BALLOU, WR ;
QUAKYI, IA ;
CARTER, R ;
TROSPER, JH ;
HOCKMEYER, WT .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1986, 35 (01) :66-68
[6]   STUDIES IN HUMAN MALARIA .1. THE PROTECTIVE ACTION OF SULFADIAZINE AND SULFAPYRAZINE AGAINST SPOROZOITE-INDUCED FALCIPARUM MALARIA [J].
COATNEY, GR ;
COOPER, WC ;
YOUNG, MD ;
MCLENDON, SB .
AMERICAN JOURNAL OF HYGIENE, 1947, 46 (01) :84-104
[7]   STUDIES OF NEUTROPENIA OF ACUTE MALARIA [J].
DALE, DC ;
WOLFF, SM .
BLOOD, 1973, 41 (02) :197-206
[8]   PLASMODIUM-FALCIPARUM - INVITRO CHARACTERIZATION AND HUMAN INFECTIVITY OF A CLONED LINE [J].
DAVIS, JR ;
CORTESE, JF ;
HERRINGTON, DA ;
MURPHY, JR ;
CLYDE, DF ;
THOMAS, AW ;
BAQAR, S ;
COCHRAN, MA ;
THANASSI, J ;
LEVINE, MM .
EXPERIMENTAL PARASITOLOGY, 1992, 74 (02) :159-168
[9]  
de Waal HA D-V, 1981, NED TIJDSCHR GENEES, V125, P375
[10]   MALARIA HEPATITIS [J].
DELLER, JJ ;
CIFARELLI, PS ;
BERQUE, S ;
BUCHANAN, R .
MILITARY MEDICINE, 1967, 132 (08) :614-+